Evaluation of the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin, and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer: A study protocol of prospective single-center, randomized controlled and open label clinical trial (RNPLS-01)
催眠药
紫杉醇
医学
肿瘤科
癌症
内科学
作者
Juan Wang,XU Guang-hui,Shushang Liu,Y Ma,Shu Wang,Mengbin Li,Yan Zhao,Haoyuan Wang,Yuhao Wang,Chaosheng Peng,Huade Huo,Haolin Li,Gang Ji,Jianjun Yang
Ramucirumab is a VEGFR2 antagonist. The aim of this trial is to evaluate the efficacy and safety of ramucirumab combined with nab-paclitaxel, lobaplatin and S-1 in neoadjuvant and conversion therapy for advanced gastric cancer.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
科研狗
null
GingerF
wanci
123
pluto
互助
nn
蓝莓橘子酱
han
ceeray23
Dean
殷勤的紫槐
zzc7
LewisAcid
寻道图强
Maestro_S
欢呼凡雁
pcr163
皖公网安备34019202002308
